Cancer cells seem to rely on a novel survival mechanism to metastasize, an early study led by Queen Mary University of London (QMUL) has found. The discovery could help with future development of novel treatments to prevent metastasis and secondary tumors.
Metastasis, the spread of cancer around the body, is one of the biggest challenges in cancer treatment.
It is often not the original tumor that kills, but secondary growths. These happen when cancer cells are able to break away from the primary site, travel around the body and ‘seed’ new tumors.
A key question in cancer research has been how cancer cells are able to survive once they break away from a tumor to spread around the body. Cells are relatively protected when they are attached to other cancer cells and their surroundings, but become more vulnerable when they detach and ‘float’, and normally undergo cell death.
“Metastasis is currently incurable and remains one of the key targets of cancer research. Our research advances the knowledge of how two key molecules communicate and work together to help cancer cells survive during metastasis. We’re hoping that this might lead to the discovery of new drugs to block the spread of cancer within the body.”
The study investigates the changes that occur in cancer cells as they break away from tumors in cell cultures, zebrafish and mice. The researchers revealed a previously unknown survival mechanism in cancer cells and found that molecules known as ‘integrins’ could be key.
Barts Cancer Institute, QMUL
Integrins are proteins on the cell surface that attach to and interact with the cell’s surroundings. ‘Outside-in’ and ‘inside-out’ signalling by integrins is known to help the cancer cells attach themselves to their surroundings.
But the study suggests that when the cancer cells are floating, as they do during metastasis, the integrins switch from their adhesion role to take on an entirely new form of communication which has never been seen before – ‘inside-in’ signalling, in which integrins signal within the cell.
Beta-1 Integrin And c-Met
The researchers discovered that an integrin called beta-1 (β1) pairs up with another protein called c-Met and they move inside the cell together.
The two proteins then travel to an unexpected location within the cell which is normally used to degrade and recycle cell material. Instead the location is used for a new role of cell communication and the two proteins send a message to the rest of the cell to resist against death while floating during metastasis.
Using both breast and lung cells, the team found that metastases were less likely to form when β1 and c-Met were blocked from entering the cell together or were prevented from moving to the special location within the cell.
Barts Cancer Institute, QMUL
Integrins are already major targets for cancer treatment with drugs either being tested or in use in the clinic.
Most integrin inhibitor drugs target their adhesive function and block them on the surface of the cancer cell. The researchers say that the limited success of these drugs could be partly explained by this newly discovered role of integrins within the cancer cell.
A new strategy could be to prevent the integrin from going inside the cell in the first place. The researchers hope that these insights could lead to the design of better therapies against metastasis and more effective treatment combinations that could prevent and slow both tumou]r growth and spread.
The team carried out part of their animal research work on zebrafish embryos in order to implement the principle of 3Rs (refine, reduce, replace) on their research on mice.
Zebrafish provide a similar tumour microenvironment to humans, meaning fewer tests need to be carried out in mice and any future experiments in mice will have been optimised to have minimal toxicity. They are aiming to reduce the number of mice used by at least 90 per cent and ultimately use zebrafish to completely replace the use of mice.